Showing results (211-220 of 365) with videos related to
Sort By:
Pageof 37
ESMO Open|October 31, 2024
Safety of solid oncology drugs in older patients: a narrative reviewA Rousseau, A Géraud, R Geiss, et al.BMC Endocrine Disorders|June 1, 2022
Comparison of the prognostic value of AJCC cancer staging system 7th and 8th editions for differentiated thyroid cancerY J Morosán Allo, L Bosio, A Morejón, et al.Bioorganic Chemistry|September 29, 2022
Chemical synthesis of fluorinated and iodinated 17β-HSD3 inhibitors and evaluation for imaging prostate cancer tumors and tissue biodistributionDonald Poirier, René Maltais, Jacques A Rousseau, et al.Experimental Cell Research|December 10, 1999
Activation of Xenopus eggs by the kinase inhibitor 6-DMAP suggests a differential regulation of cyclin B and p39(mos) proteolysisJ F Bodart, D Béchard, M Bertout, et al.Presse Medicale (Paris, France : 1983)|November 23, 2005
[Osteofluorosis caused by excess use of toothpaste]J Roos, A Dumolard, S Bourget, et al.Therapeutic Drug Monitoring|February 17, 2007
Population pharmacokinetics and bayesian estimator of cyclosporine in pediatric renal transplant patientsS Irtan, F Saint-Marcoux, A Rousseau, et al.Leukemia|April 1, 1994
Potential strategies for circumventing myeloperoxidase-catalyzed degradation of vinca alkaloidsD Schlaifer, M R Cooper, M Attal, et al.Journal of Neuro-Oncology|March 1, 2005
T cell response to Hu-D peptides in patients with anti-Hu syndromeA Rousseau, B Benyahia, J Dalmau, et al.Therapeutic Drug Monitoring|January 30, 2004
Population pharmacokinetic modeling of oral cyclosporin using NONMEM: comparison of absorption pharmacokinetic models and design of a Bayesian estimatorA Rousseau, F Léger, Y Le Meur, et al.Cytotherapy|September 30, 2008
Flanking-sequence exponential anchored-polymerase chain reaction amplification: a sensitive and highly specific method for detecting retroviral integrant-host-junction sequencesM A Pule, A Rousseau, J Vera, et al.Pageof 37